Matthew L. Posard Halozyme Therapeutics, Inc. (HALO) insider trading activity

HALO Quotes by TradingView

Matthew L. Posard is of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 74,039 shares of HALO, which is worth approximately $4.49 Million. The most recent transaction as insider was on May 01, 2025, when has been sold 4,165 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 74K
5.96% 3M change
38.17% 12M change
Total Value Held $4.49 Million

Matthew L. Posard Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 01 2025
BUY
Grant, award, or other acquisition
-
4,165 Added 5.33%
74,039 Common Stock
Aug 14 2024
SELL
Open market or private sale
$570,133 $57.7 p/Share
9,881 Reduced 12.39%
69,874 Common Stock
Aug 13 2024
SELL
Open market or private sale
$561,900 $56.19 p/Share
10,000 Reduced 11.14%
79,755 Common Stock
Aug 12 2024
SELL
Open market or private sale
$557,200 $55.72 p/Share
10,000 Reduced 10.02%
89,755 Common Stock
Jun 12 2024
SELL
Open market or private sale
$506,200 $50.62 p/Share
10,000 Reduced 9.11%
99,755 Common Stock
Jun 11 2024
SELL
Open market or private sale
$500,100 $50.01 p/Share
10,000 Reduced 8.35%
109,755 Common Stock
Apr 25 2024
BUY
Grant, award, or other acquisition
-
6,501 Added 5.15%
119,755 Common Stock
May 05 2023
BUY
Grant, award, or other acquisition
-
8,065 Added 6.65%
113,254 Common Stock
Dec 06 2022
SELL
Open market or private sale
$561,200 $56.12 p/Share
10,000 Reduced 8.68%
105,189 Common Stock
Dec 05 2022
SELL
Open market or private sale
$557,400 $55.74 p/Share
10,000 Reduced 7.99%
115,189 Common Stock
Dec 02 2022
SELL
Open market or private sale
$588,000 $58.8 p/Share
10,000 Reduced 7.4%
125,189 Common Stock
May 05 2022
BUY
Grant, award, or other acquisition
-
6,206 Added 4.39%
135,189 Restricted Stock Units
May 05 2021
BUY
Grant, award, or other acquisition
-
5,230 Added 3.9%
128,983 Restricted Stock Units

Also insider at

DMTK
DermTech, Inc. Healthcare
Director
TLIS
Talis Biomedical Corp Healthcare
Director
NAUT
Nautilus Biotechnology, Inc. Healthcare
Director
MLP

Matthew L. Posard

San Diego, CA

Track Institutional and Insider Activities on HALO

Follow HALOZYME THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HALO shares.

Notify only if

Insider Trading

Get notified when an Halozyme Therapeutics, Inc. insider buys or sells HALO shares.

Notify only if

News

Receive news related to HALOZYME THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HALO